The Nuffield Department of Medicine (NDM) has been working with local researchers in Mexico for a number of years – a collaboration that was initially spurred by NDM’s Professor Arturo Reyes-Sandoval’s interest in malaria and dengue, but which now includes several other diseases endemic in Mexico, including chikungunya, Chagas and most recently Zika diseases.
This collaboration has also been spurred by the need for developing local research capacity in low and middle income countries, as recognized by the World Health Organization’s 2013 report, which explicitly calls for more locally-led research. The Global Health Network argues that “there are still far too few locally-led research studies that are conceived, planned, led and operated by researchers from and in LMICs (low and middle-income countries). There are compounding reasons for this but the lack of access to support, training, tools and resources are important factors in this gap.’
Our aim is therefore to foster the development of Mexican scientific leadership and research capabilities, and to help bridge the gap between research outputs produced in Latin America versus Europe. To achieve this aim, we are now hosting a new project to develop scientific infrastructure and research capacity for vaccine development and genomic research across Mexico.
NDM has a growing spread of research relying on collaborations with world-class scientists, research, hospitals and public health institutes in Mexico and Latin America, and on direct access to infrastructure or patient cohorts in Mexico itself. In addition, there are a growing number of scientists and research institutes based in Mexico who are seeking collaborations abroad. In addition, there are a growing number of scientists and research institutes based in Mexico who are seeking collaborations abroad.Read more